KMB vs VXRT · P/E 19, rev $20.06B vs rev $28.7M
Kimberly-Clark Corporation (KMB) versus Vaxart Inc (VXRT) — a side-by-side from cached financials, not a winner call.
Kimberly-Clark Corporation (KMB) is a household & personal products company listed on US.
Vaxart Inc (VXRT) is a biotechnology company listed on US.
Latest reported KMB revenue for 2024-12-31 was $20.06B. Net income was $2.58B. Revenue was down 1.8% from 2023-12-31 to 2024-12-31. KMB currently screens at market cap $32.88B and trailing P/E 19.2.
Latest reported VXRT revenue for 2024-12-31 was $28.7M. Net income was -$66.9M. Revenue was up 288.9% from 2023-12-31 to 2024-12-31. VXRT currently screens at market cap $73.0M.
KMB currently screens at market cap $32.88B and trailing P/E 19.2. VXRT currently screens at market cap $73.0M.
Not investment advice. Open the KMB and VXRT stock pages for the full models.
Not investment advice.